With 2014 drawing to a close, biotech investors are probably wondering which stocks to stuff in their stockings for next year. While there are plenty of promising biotech stocks to choose from, we should also take note of three high-risk, low-growth biotech stocks that investors might consider avoiding: Inovio Pharmaceuticals , VIVUS , and Zogenix .Inovio Pharmaceuticals At first glance, […]
Original article:
Biotech Stocks Sell Off, ETFs Fall Over 5%
[…]
0% APR Credit CardsAirline Credit CardsBalance Transfer Credit CardsBusiness Credit CardsCash Back Credit CardsCharge CardsCharge Cards for BusinessGas CardsHome Improvement Rewards Credit CardsInstant Approval Credit CardsLow Interest Credit CardsNo Annual Fee Credit CardsNo Foreign Transaction Fee Credit CardsPoints Rewards Credit CardsPrepaid & Debit CardsReward Credit CardsStudent Credit CardsTop 10 Best Credit Card Deals and Offers
Cards for Bad CreditCredit Quality AverageCredit […]
Source: Celgene CorpBiotech stocks are notorious for their stratospheric gains and subterranean losses, especially clinical stage biotech stocks that develop promising, yet unproven, next-generation drugs. Those emerging biotech stocks may offer the potential for outsized returns, but they also carry significant risks. To help investors decide which of these clinical-stage companies may be worth considering in 2015, we asked three […]
Continue at source:
Top Marijuana Penny Stocks for 2014: Consulting, Biotech and Infused Products Win
[…]
Source: Flickr user Mark EsauBargain hunters are often attracted to beaten-down biotech stocks because they sometimes rebound in astonishing fashion. That said, it can be extremely difficult to separate the wheat from the chaff when mulling over such companies, with many of them having little to no hope of ever reliving their glory days.Aegerion Pharmaceuticals , MannKind Corp. , and […]
LONDON, December 22, 2014 /PRNewswire/ –Investor-Edge has initiated coverage on the following equities: Achillion Pharmaceuticals Inc. (NASDAQ: ACHN), Arrowhead Research Corporation (NASDAQ: ARWR), Sunesis Pharmaceuticals Inc. (NASDAQ: SNSS), Array BioPharma Inc. (NASDAQ: ARRY), and Seattle Genetics Inc. (NASDAQ: SGEN). Free research on these five companies can be accessed at: http://investor-edge.com/register. The US markets on Friday, December 19, 2014, ended on […]
Source: Celgene Corp.The volatility that comes with investing in biotech stocks can test the patience of even the most risk-tolerant investor. Many investors may be better served focusing on companies with proven track records of success rather than concentrating on emerging biotech stocks that are more promise than profit. Fortunately, investing in proven performers doesn’t have to mean sacrificing growth! […]
C3BS enrols 240th patient in CHART-1 European trial of C-Cure for treatment of congestive heart failure | Biotech License
Select CategoryBiotech Articles (22)Biotech FAQ (222)Biotech News (465)Biotech Patents (47)Biotech Videos (37)Pharmaceutical News (124)
Link:
C3BS enrols 240th patient in CHART-1 European …
See which stocks are being affected by Social Media
[…]
Source:
Cramer: Watch out Regeneron, here comes Isis
[…]
